OpenBilldrug price receipt

NADAC week of 2026-10-14

FIRVANQ 50 MG/ML SOLUTION

FDA nonproprietary name: vancomycin hydrochloride

For 1 mL

Pharmacies pay

$1.19 filed

1 × $1.18602 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$0.92 filed

1 × $0.92382 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.78× estimated

Medicare paid 22% less than pharmacies pay.

Part D averages every strength and form sold under “Firvanq” / “Vancomycin HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.37 estimated

$1.19 + $0.18 (15%) + $5.00 fee per fill = $6.37

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FIRVANQ 50 MG/ML SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as vancomycin hydrochloride, under the trade name “FIRVANQ”.

FDA gives its dosage form as kit.

The labeler, the company named on the label, is Azurity Pharmaceuticals, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 65628-0206-05.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.19 for 1 mL (1 × $1.18602 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-01-01. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-01-01. The file is new; the price is not.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.70181 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name vancomycin hydrochloride with FIRVANQ 50 MG/ML SOLUTION.

ProductPharmacies pay per unitMedicare per unit
FIRVANQ 50 MG/ML SOLUTION this page
brand · kit
$1.18602 per ML filed
eff. 2026-01-01
$0.92382 per ML filed
Part D 2024 average
VANCOMYCIN 25 MG/ML ORAL SOLN
generic · kit
$0.39002 to $0.67288 per ML filed
eff. 2026-09-23
We don’t know yet
VANCOMYCIN 50 MG/ML ORAL SOLN
generic · kit
$0.70181 to $0.8007 per ML filed
eff. 2025-12-17 to 2026-09-23
We don’t know yet
VANCOMYCIN 250 MG/5 ML ORAL SOL
generic · powder, for solution / solution
$0.70181 to $2.90936 per ML filed
eff. 2025-12-17 to 2026-09-23
We don’t know yet
VANCOMYCIN 500 MG VIAL
generic · injection, powder, lyophilized, for solution
$2.3054 per EA filed
eff. 2025-12-17
$1.60 per EA derived
Part B limit 2026 Q4
VANCOMYCIN HCL 125 MG CAPSULE
generic · capsule
$1.32898 per EA filed
eff. 2026-09-23
We don’t know yet
VANCOMYCIN HCL 250 MG CAPSULE
generic · capsule
$2.59757 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-17, 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part D paid $0.92 for 1 mL, at an average of $0.92382 per ML in 2024 (2024-01-01 to 2024-12-31) for “Firvanq” and “Vancomycin HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,932 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FIRVANQ 50 MG/ML SOLUTION labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Firvanq / Vancomycin HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 1 mL?
The FDA package description of NDC 65628-0206-05 (“1 KIT in 1 CARTON (65628-206-05) * 7.5 g in 1 BOTTLE * 145 mL in 1 BOTTLE”) does not give one amount in mL, NADAC’s unit for this product. So the card starts at 1 ML; change it to match your prescription.